The table below shows Eton Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$79.95M
$39.01M
$31.64M
$21.25M
$21.83M
$39.00K
Cost of revenue
$37.21M
$15.60M
$10.58M
$6.93M
$2.83M
$436.00K
Gross profit
$42.74M
$23.41M
$21.06M
$14.32M
$19.00M
-$397.00K
R&D
$7.76M
$3.25M
$3.32M
$4.00M
$6.24M
$14.10M
ETON annual revenue (10-K history)
Eton Pharmaceuticals, Inc. reported annual revenue of $79.95M for fiscal year 2025. That is up 104.9% from $39.01M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $959.00K (FY 2019) to $79.95M. Figures come from the company's audited annual reports as filed with the SEC.